Actively Recruiting

Age: 66Years +
All Genders
NCT07333131

Identification of Iatrogenic Drug Events Upon Admission to the Adult Emergency Departments

Led by University Hospital, Strasbourg, France · Updated on 2026-01-12

100

Participants Needed

1

Research Sites

43 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Pharmacists working within a multidisciplinary team have a role to play in detecting the potential iatrogenic origin of a hospital admission, in order to implement measures to improve medication use appropriately and limit readmissions for medication-related iatrogenesis. The iatrogenic detection process depends on the individual involved, their experience, and any tools consulted. Indeed, detection aids have their place in this process and aim for better identification. For example, a questionnaire called AT HARM 10 was developed by a team of experienced pharmacists to identify hospitalizations related to medication-related iatrogenesis. The use of this tool has been validated for pharmacists as well as for pharmacy students: interns and fifth-year medical students. Identifying iatrogenic drug events among patients presenting to the emergency department using the AT HARM 10 grid in order to intervene and adapt therapeutic management. This clinical pharmacy activity complements what is already included in routine care (medication review, pharmaceutical analysis, and pharmaceutical intervention to adapt treatment).

CONDITIONS

Official Title

Identification of Iatrogenic Drug Events Upon Admission to the Adult Emergency Departments

Who Can Participate

Age: 66Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patient (> 65 years old)
  • Treated in the emergency department of Hautepierre Hospital
  • Presenting a prioritization score > 7 according to the Von Korff score
  • Subject (and their legal representative, if applicable) not objecting to the reuse of their data for scientific research purposes.
Not Eligible

You will not qualify if you...

- Presence of a written objection in the patient's medical file (and/or that of their legal representative, if applicable) to the reuse of their data for scientific research purposes

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Service de Pharmacie - Stérilisation - CHU de Strasbourg - France

Strasbourg, France, 67091

Actively Recruiting

Loading map...

Research Team

J

Julia WALTHER, PharmD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here